Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Prioritizing primary care in HIV: comorbidity, toxicity, and demography.

Justice AC.

Top HIV Med. 2006 Dec-2007 Jan;14(5):159-63.

2.

Renal disease and toxicities: issues for HIV care providers.

Fine DM.

Top HIV Med. 2006 Dec-2007 Jan;14(5):164-9.

3.

Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.

Starace F, Ammassari A, Trotta MP, Murri R, De Longis P, Izzo C, Scalzini A, d'Arminio Monforte A, Wu AW, Antinori A; AdICoNA Study Group. NeuroICoNA Study Group..

J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S136-9. Review.

PMID:
12562037
4.

Medical interventions for addictions in the primary care setting.

Bruce RD.

Top HIV Med. 2010 Feb-Mar;18(1):8-12. Review.

5.

Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.

Celentano DD, Lucas G.

Clin Infect Dis. 2007 Dec 15;45 Suppl 4:S318-23. doi: 10.1086/522557.

PMID:
18190306
6.

Triple diagnosis: dual diagnosis and HIV disease, Part 1.

Douaihy AB, Jou RJ, Gorske T, Salloum IM.

AIDS Read. 2003 Jul;13(7):331-2, 339-41. Review.

PMID:
12889451
7.

Behavioral aspects of HIV care: adherence, depression, substance use, and HIV-transmission behaviors.

Berg CJ, Michelson SE, Safren SA.

Infect Dis Clin North Am. 2007 Mar;21(1):181-200, x. Review.

PMID:
17502235
8.

Update on cardiovascular complications in HIV infection.

Currier JS.

Top HIV Med. 2009 Jul-Aug;17(3):98-103. Review.

9.
10.

HIV testing: rationale for changing recommendations.

Janssen RS.

Top HIV Med. 2007 Feb-Mar;15(1):6-10.

11.

End-stage liver disease in HIV disease.

Peters MG.

Top HIV Med. 2009 Sep-Oct;17(4):124-8.

12.

Immunizations for HIV-infected adults: indications, timing, and response.

Spach DH.

Top HIV Med. 2006 Dec-2007 Jan;14(5):154-8.

13.

The role of adherence to antiretroviral therapy in the management of HIV infection.

Conway B.

J Acquir Immune Defic Syndr. 2007 Jun 1;45 Suppl 1:S14-8. Review.

PMID:
17525686
14.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida..

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
15.

Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.

Kapadia F, Vlahov D, Wu Y, Cohen MH, Greenblatt RM, Howard AA, Cook JA, Goparaju L, Golub E, Richardson J, Wilson TE.

Am J Drug Alcohol Abuse. 2008;34(2):161-70. doi: 10.1080/00952990701877052.

PMID:
18293232
16.

Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.

Muga R, Langohr K, Tor J, Sanvisens A, Serra I, Rey-Joly C, Muñoz A.

Clin Infect Dis. 2007 Aug 1;45(3):370-6. Epub 2007 Jun 19.

PMID:
17599317
17.

Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.

Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Uldall KK, Ettner SL.

J Ment Health Policy Econ. 2009 Mar;12(1):33-46.

PMID:
19346565
18.

Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.

Protopopescu C, Raffi F, Roux P, Reynes J, Dellamonica P, Spire B, Leport C, Carrieri MP; ANRS CO8 APROCO-COPILOTE Study Group..

J Antimicrob Chemother. 2009 Sep;64(3):599-606. doi: 10.1093/jac/dkp232. Epub 2009 Jul 14.

PMID:
19602563
19.

Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).

Spire B, Lucas GM, Carrieri MP.

Int J Drug Policy. 2007 Aug;18(4):262-70. Epub 2007 Jan 26. Review.

PMID:
17689374
20.

Improved survival in HIV-infected persons: consequences and perspectives.

Lohse N, Hansen AB, Gerstoft J, Obel N.

J Antimicrob Chemother. 2007 Sep;60(3):461-3. Epub 2007 Jul 2.

PMID:
17609196

Supplemental Content

Support Center